examines current advances in the study of the role of miRNAs in
cancer, including
prostate cancer. Issues
Gilyazova, I.R.,
Yankina, M.A.,
Kunsbaeva, G.B.,
Klimentova, E.A.,
Izmaylov, A.A.,
V.N. Pavlov,
Khusnutdinova, E.K. (2016) patient. Bioinformatics analysis was conducted and the most significant mutations in
prostate cancerGilyazova, I.R.,
Ivanova, E.A.,
Bermisheva, M.A.,
Loginova, M.V.,
Asadullina, D.D.,
Ishemgulov, R.R.,
Mustafin, A.T.,
Pavlov, V.N.,
Khusnutdinova, E.K. (2022) of PTEN, rs17878362 of TP53, and rs2699887 of PIK3CA with the risk of
prostate cancer development. As a
Mingazheva, E.T.,
Prokofyeva, D.S.,
Valova, Ya.V.,
Andreeva, E.A.,
Nurgalieva, A.Kh.,
Valiev, R.R.,
Ekomasova, N.V.,
Faishanova, R.R.,
Romanova, A.R.,
Khusnutdinova, E.K. (2022) The high risk of ovarian
cancer is primarily associated with mutations in BRCA1 and BRCA2 genes
Fedorova, Yu Yu,
Sagitova, A.V.,
Mingazheva, E.T.,
Faishanova, R.R.,
Zagitov, I.R.,
Andreeva, E.A.,
Nurgalieva, A.Kh.,
Khusnutdinova, E.K.,
Darvish, M.,
Prokofyeva, D.S. (2024) with neoplasm development and progression, such as
cell proliferation and differentiation, apoptosis
GILYAZOVA, I.R.,
KLIMENTOVA, E.A.,
BERMISHEVA, M.A.,
KHUSNUTDINOVA, E.K.,
IZMAILOV, A.A.,
GALIMOVA, E.F.,
SAFIULLIN, R.I.,
GALIMOV, S.N.,
V.N. Pavlov,
BULYGIN, K.V. (2020) in patients with metastatic clear
cell renal
cell carcinoma (ccRCC). Analysis of microRNA expression
Fedorova, Yu. Yu.,
Aminova, E.T.,
Faishanova, R.R.,
Zagitov, I.R.,
Romanova, A.R.,
Nurgalieva, A.Kh.,
Andreeva, E.A.,
Darvish, M.,
Khusnutdinova, E.K.,
Prokofyeva, D.S. (2025) Ovarian
cancer remains one of the most common causes of death from gynecological
cancer in women